Llwytho...
Longitudinal plasma phosphorylated tau 181 tracks disease progression in Alzheimer’s disease
To assess plasma phosphorylated tau181 (p-tau181) as a progression biomarker in Alzheimer’s disease (AD), we examined longitudinal plasma p-tau181 of 1184 participants (403 cognitively normal (CN), 560 patients with mild cognitive impairment (MCI), and 221 with AD dementia) from Alzheimer’s Disease...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Transl Psychiatry |
|---|---|
| Prif Awduron: | , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Nature Publishing Group UK
2021
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8197760/ https://ncbi.nlm.nih.gov/pubmed/34120152 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41398-021-01476-7 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|